Similar Search Results

Uitility bond rates and tax normalization

Berndt, Ernst R.; Sharp, Karen Chant; Watkins, Gordon … - In: The journal of finance : the journal of the American … 34 (1979) 5, pp. 1211-1220

Persistent link: https://www.econbiz.de/10003490880

The value of antihypertensive drugs : a perspective on medical innovation

Cutler, David M.; Long, Genia; Berndt, Ernst R.; Royer, … - In: Health affairs : at the intersection of health, health … 26 (2007) 1, pp. 97-110

Persistent link: https://www.econbiz.de/10003434340

Advance market commitments for vaccines against neglected diseases : estimating costs and effectiveness

Berndt, Ernst R.; Glennerster, Rachel; Kremer, Michael; … - 2006

Persistent link: https://www.econbiz.de/10003406805

Opportunities for improving the drug development process : results from a survey of industry and the FDA

Berndt, Ernst R.; Gottschalk, Adrian H. B.; Strobeck, … - In: Innovation policy and the economy 6 (2006), pp. 91-121

Persistent link: https://www.econbiz.de/10003375038

Brand loyalty, generic entry and price competition in pharmaceuticals in the quarter century after the 1984 Waxman-Hatch legislation

Berndt, Ernst R.; Aitken, Murray L. - 2010

"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. The landmark Waxman-Hatch Act of 1984 represented a "grand compromise" legislation that sought to balance incentives for innovation by...

Persistent link: https://www.econbiz.de/10008688817